Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Christopher Hook

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|July 7, 2023
Bortezomib and daratumumab in refractory autoimmune hemolytic anemiaJohn McGlothlin, Jithma Abeykoon, Eyad Al-Hattab, et al.
Annals of Hematology|March 17, 2019
Patterns and utility of vitamin B12 and folate testing in patients with isolated thrombocytopeniaEmma P DeLoughery, Aishwarya Ravindran, Aneel A Ashrani, et al.
European Journal of Haematology|April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomesJordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, et al.
American Journal of Hematology|September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelideAyalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.
American Journal of Hematology|April 22, 2020
The differential diagnosis of basophilia in patients undergoing BCR-ABL testingCaleb J Smith, Lindsey Ann Kluck, Gordon J Ruan, et al.
American Journal of Hematology|February 2, 2021
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapyKebede H Begna, Naseema Gangat, Aref Al-Kali, et al.
Leukemia & Lymphoma|October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapyMing Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
Mayo Clinic Proceedings|March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease SubgroupsNatasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
American Journal of Hematology|September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational statusKebede H Begna, Walid Ali, Naseema Gangat, et al.
American Journal of Hematology|April 25, 2017
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemiaAishwarya Ravindran, Janani Sankaran, Eapen K Jacob, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|July 7, 2023
Bortezomib and daratumumab in refractory autoimmune hemolytic anemiaJohn McGlothlin, Jithma Abeykoon, Eyad Al-Hattab, et al.
Annals of Hematology|March 17, 2019
Patterns and utility of vitamin B12 and folate testing in patients with isolated thrombocytopeniaEmma P DeLoughery, Aishwarya Ravindran, Aneel A Ashrani, et al.
European Journal of Haematology|April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomesJordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, et al.
American Journal of Hematology|September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelideAyalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.
American Journal of Hematology|April 22, 2020
The differential diagnosis of basophilia in patients undergoing BCR-ABL testingCaleb J Smith, Lindsey Ann Kluck, Gordon J Ruan, et al.
American Journal of Hematology|February 2, 2021
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapyKebede H Begna, Naseema Gangat, Aref Al-Kali, et al.
Leukemia & Lymphoma|October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapyMing Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
Mayo Clinic Proceedings|March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease SubgroupsNatasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
American Journal of Hematology|September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational statusKebede H Begna, Walid Ali, Naseema Gangat, et al.
American Journal of Hematology|April 25, 2017
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemiaAishwarya Ravindran, Janani Sankaran, Eapen K Jacob, et al.
Pageof 5